Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-44.3M | $-24.3M | $-64.1M | $-77.2M | $-77.8M | $-72.9M | $-72.7M | $-65.8M |
| Depreciation & Amortization | $1.9M | $1.3M | $1.4M | $900.0K | $274.0K | $277.0K | $584.0K | $110.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.0M | $1.0M | — | $600.0K | — | — | — | — |
| Stock-Based Compensation | $22.2M | $25.4M | $25.5M | $26.5M | $27.0M | $29.8M | $29.3M | $29.8M |
| Net Cash from Operating Activities | $-17.6M | $-6.3M | $-35.6M | $-54.9M | $-45.9M | $-36.0M | $-41.0M | $-34.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $205.0K | $40.0K | $145.0K | $154.0K | $8.0K | $124.0K | $557.0K | $65.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-38.8M | $-40.0K | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $73.8M | $3.1M | — | — | — | — | — | — |
| Net Change in Cash | $17.4M | $-3.1M | $2.0M | $-1.1M | $-24.3M | $-89.4M | $142.0M | $-5.3M |
| Free Cash Flow | $-17.8M | $-6.3M | $-35.8M | $-55.1M | $-45.9M | $-36.2M | $-41.5M | $-35.0M |